Objectives To identify whether lncRNAs (long noncoding RNA) participate in the regulation of cisplatinresistant induced autophagy in endometrial cancer cells. Results Autophagy activity was significantly boosted in cisplatin-resistant Ishikawa cells, a human endometrial cancer cell line, compared with that in parental Ishikawa cells. After analyzing the overall long noncoding RNA (lncRNA) profiling, a meaningful lncRNA, HOTAIR, was identified. It was downregulated simultaneously in cisplatin-resistant Ishikawa cells and parental Ishikawa cells treated with cisplatin. RNA interference of HOTAIR reduced the proliferation of cisplatin-resistant Ishikawa cells and enhanced the autophagy activity of cisplatin-resistant Ishikawa cells with or without cisplatin treatment, in addition, beclin-1, multidrug resistance (MDR), and P-glycoprotein (P-gp) were mediated by lncRNA HOTAIR. Conclusions It is clear that lncRNAs, specifically HOTAIR, can regulate the cisplatin-resistance ability of human endometrial cancer cells through the regulation of autophagy by influencing Beclin-1, MDR, and P-gp expression.
Introduction
One of the common cancers of the uterine is endometrial cancer and this gynecological malignancy is present worldwide. Currently, cisplatin, one of the platinum drugs, is regarded as the first line treatment of endometrial cancer in either adjuvant or neoadjuvant settings. Although cisplatin-based treatment prolongs the cancer progression-free intervals, the actual survival rate is unaltered, due to the development of chemoresistance. Therefore, to effectively treat endometrial cancer, the key objective is focused on resolving the problem of chemoresistance.
Autophagy is a major cellular process that captures intracellular organelles and cytoplasmic materials into autophagosomes, and delivers them to the lysosomal compartment where they are degraded and recycled (Mizushima 2010) . Autophagy mediates the chemoresistance (Sui et al. 2013) ; specifically one of the mechanisms of cisplatin-resistance in ovarian and endometrial cancer has been demonstrated to correlate with autophagy (Fukuda et al. 2015) . However, the detailed contributions of autophagy to cisplatin-resistant endometrial cancer remain extremely limited.
Many long non-coding RNA (lncRNA) have a role in mediating the chemoresistance of cancer cells (Liu et al. 2013 (Liu et al. , 2015 . However, the underlying mechanisms are not well documented and whether lncRNA participates in the regulation of chemoresistanceinduced autophagy in endometrial cancer remains unknown.
Herein, a meaningful lncRNA, HOTAIR, was identified and evidenced to be a tumor chemoresistant promoter and the mechanism of regulating autophagy contributing to the cisplatin-induced resistance in endometrial cancer cells was investigated.
Methods

Cell culture and treatment
The Ishikawa human endometrial cancer cell line and its cisplatin-resistant sub-clone were used in the in vitro studies. For cisplatin treatment, both cell lines were seeded into 96-well plates at 2 9 10 3 cells/well and incubated with DMEM containing cisplatin (0-80 lg/ml) for the indicated times.
Autophagy assay using the DsRed-LC3-GFP reporter A ptfLC3 (Addgene plasmid 21074) was used to develop a dual-color autophagy reporter. This is an mRFP-green fluorescence protein (GFP) tandem fluorescent-tagged LC3 (also known as ATG8) plasmid in that DsRed protein is fused with the N-terminus of LC3 protein and the C-terminus of the protein is connected to EGFP. In order to produce stable cell lines continuously reporting autophagy activity, recombinant retroviruses expressing the DsRed-LC3-GFP reporter were generated and used to infect target cells.
LncRNA profiling
To identify the involved lncRNAs, Human Diseaserelated LncRNA Profiler (System Biosciences) was used and overall lncRNAs were selected from either the RNA database (http://research.imb.uq.edu.au/ rnadb/Default.aspx) or lncRNA database (www. lncRNAdb.org). All the lncRNAs were listed in Supplementary Table 1 . Total RNA was extracted from Ishikawa human endometrial cancer cell line and its cisplatin-resistant sub-clone pretreated with or without cisplatin. Reverse transcription for lncRNAs was carried out by using RevertAid Reverse Transcriptase (Fermentas) with random primer mix (New England BioLabs). Primers of lncRNAs were listed in Supplementary Table 2 . GAPDH was used as an internal control. The values for the cells without treatment after normalization by the internal controls served as a basal level of expression of indicated lncRNAs; deltadelta Ct values (no treatment versus carboplatin plus docetaxel treatment) were used to determine their relative expression as fold changes.
RNA interference
The sequences of siRNA corresponding to lncRNA HOTAIR were synthesized (Qiagen). Ishikawa human endometrial cancer cell line and its cisplatin-resistant sub-clones were respectively transfected with three HOTAIR siRNAs (100 nM) using Lipofectamine 2000. Scrambled siRNA was used as negative control and cells were harvested post-transfection for the CCK-8 assay.
Cell proliferation assay
Cell proliferation was analyzed by using CCK-8 assay kit (Dojindo) according to the manufacturer instructions. Briefly cells were incubated in the medium containing cisplatin in the absence or presence of small interference RNA (siRNA) against HOTAIR in 96-well plates for indicated times. This was followed by the addition of 5 ll CCK-8 reagent to each well and the samples were further incubated at 37°C for 1 h.
The cell numbers were assessed from the A 450 value. All the experiments were performed in triplicate.
Cell apoptosis assay
Cells were harvested, washed with ice-cold PBS, and stained with annexin V-fluorescein isothiocyanate (FITC) apoptosis detection kits (KeyGEN Biotech, Nanjing, China). Cell apoptosis was analyzed in a flow cytometer (BD Biosciences).
Western blotting
The expression levels of proteins were determined by western blotting using the enhanced chemiluminescent substrate (ECL, BioRad, Richmond, CA, USA) in accordance with the manufacturer's instruction.
Statistical analysis
All data were expressed as mean ± standard deviation (SD) and subjected to analysis of variance (ANOVA) to assess the treatment effects by using SPSS 13.0 software. The Student's t test was used to determine the statistically significant differences in numbers with two significant levels (0.05 and 0.01).
Results
Identification of cisplatin-resistant Ishikawa human endometrial cancer cell line
A CCK8-based proliferation assay was used to investigate the growth suppressive effect of cisplatin (CP) on Ishikawa and its resistant cell line (Ishikawa CP). Treatment with cisplatin inhibited cell proliferation in a dose-dependent manner, in which the cell viability of Ishikawa CP was higher than its sensitive cell line ( Supplementary Fig. 1a) . Moreover, the halfmaximal inhibitory concentration (IC 50 ) values were approximately 20 and 60 lg/ml for Ishikawa and its resistant cell line ( Supplementary Fig. 1b ). These findings confirm that the cisplatin-resistant Ishikawa cell sub-clone was selected.
Ishikawa CP shows higher autophagy
To examine whether Ishikawa CP possesses increased autophagy, a dual color DsRed-LC3-GFP reporter was used, which is modified formation of the classical GFP-tagged LC3 reporter introducing two readouts for autophagy activity. The reporter has GFP separated from the C-terminus of LC3 by a recognition site for the autophagic protease, ATG4, and decreased GFP fluorescence means increased autophagy. Ishikawa CP presented a significantly reduced GFP fluorescence in contrast to normal Ishikawa cells, indicating the abnormal autophagy activity in Ishikawa CP (Fig. 1a) . Additionally, more autophagosomes were detected in Ishikawa CP (Fig. 1b) . These data suggest that higher autophagy is likely to be positively involved in the cisplatin resistance in Ishikawa CP.
Differential expression of lncRNAs between Ishikawa CP and normal Ishikawa cell
The involvement of lncRNAs in the altered autophagy of Ishikawa CP was investigated. The expression of lncRNAs in normal Ishikawa and Ishikawa CP with or without CP treating was detected. Tumor-related lncRNAs were selected for analysis most of these (Supplementary Fig. 2a ). Among these differential lncRNAs, HOTAIR presented the least expression in Ishikawa CP, and Ishikawa and Ishikawa CP in presence of CP treatment in contrast to normal Ishikawa ( Supplementary Fig. 2b , Supplementary Table 3 ). Although the least expression of lncRNA HOTAIR was shown in Ishikawa CP in absence and presence of CP, the expression of lncRNA HOTAIR in these two groups was identical (Supplementary Fig. 2b ), indicating that CP treatment possiblechanges the expression of HOTAIR in Ishikawa CP.
HOTAIR ensures higher proliferation of Ishikawa CP in CP treatment
To examine the mechanism that links HOTAIR to the CP-resistant activity of Ishikawa CP, HOTAIR was knocked down by using RNA interference technique. Primarily, three HOTAIR siRNA were selected, and endogenous HOTAIR mRNA level was analyzed by RT-PCR and detected to be lower in HOTAIR siRNA2-transfected cells as compared to cells transfected with scrambled siRNA control, demonstrating the effectiveness of HOTAIR siRNA2 (Fig. 2a) . As treating with CP suppressed the expression of HOTAIR and Ishikawa CP showed the fewer expression of HOTAIR, the effect of HOTAIR inhibition on anti-CP resistant action was analyzed. Interestingly, the HOTAIR siRNA-transfected cells (including normal Ishikawa and Ishikawa CP) displayed a specific reduction in cell proliferation and a significant increase in cell apoptosis as compared to the controltransfected cells through CCK-8 assay (Fig. 2b) and flow cytometry detection (Fig. 2c ).
Higher autophagy of Ishikawa CP is dependent on LncRNA HOTAIR
The HOTAIR siRNA treatment did not impact on the autophagy activity in Ishikawa, but improved the autophagy activity in Ishikawa treating with CP. And this was confirmed by the decrease of GFP fluorescence intensity as readout for enhanced autophagy. In contrast, HOTAIR siRNA markedly induced the autophagy activity in Ishikawa CP in absence andpresence of CP treatment (Fig. 3) . These observations indicate that a CP resistance-related lncRNA, HOTAIR, plays a significantly positive role in autophagy activity in endometrial cancer.
LncRNA HOTAIR regulates the expression of autophagy regulator, Beclin-1 Given the positive inter-relationship between autophagy activity and HOTAIR expression, the expression of the autophagy regulator, Beclin-1, was measured by using HOTAIR siRNA. In normal cells, Ishikawa CP represented higher expression of Beclin-1 than Ishikawa cells, and HOTAIR siRNA significantly down-regulated the expression of Beclin-1 in both cell lines. Upon the CP treatment, significantly more expression of Beclin-1 was observed in Ishikawa CP cells compared with that in Ishikawa cells. Moreover, HOTAIR siRNA treatment resulted in decreases in Beclin-1 expression in Ishikawa CP cells (Fig. 4) . These results demonstrate that HOTAIR may control the autophagy activity of endometrial cancer by mediating the expression of Beclin-1.
LncRNA HOTAIR regulates the expression of MDR and P-gp
To assess the potential interaction between HOTAIR and resistance-related proteins, the expression level of MDR and P-gp in Ishikawa and Ishikawa CP cells with or without transfection with HOTAIR siRNA were examined by western blot analysis (Fig. 4) . Originally, Ishikawa CP cells highly expressed MDR and P-gp. After incubating with CP only, the expressions of these two proteins were up-regulated in both Ishikawa cell lines. Upon the HOTAIR siRNA only transfection, the protein levels of MDR and P-gp were significantly reduced in Ishikawa CP cells. When CP and HOTAIR administration was integrated siRNA, MDR, and P-gp presented declined protein levels in both Ishikawa cell lines in contrast to that in only CP treatment, thereby eliciting a possible transfection with HOTAIR siRNA in Ishikawa CP cells making it partially sensitive to cisplatin because of decreased MDR and P-gp expression.
Discussion
Cisplatin is a commonly used chemotherapy drug and is the first choice for endometrial cancer; however, acquired cisplatin resistance limits its efficacy clinical chemotherapy. In this study, we found that the HOTAIR expression level was significantly decreased in cisplatin-resistant Ishikawa CP cells compared with parental Ishikawa cells. The HOTAIR inhibition appeared to reverse the chemoresistance of Ishikawa CP cells to cisplatin and appeared to function as a tumor chemoresistant promoter by regulating the expression of Beclin-1, MDR, and P-glycoprotein. HOTAIR, with a length of 2158 bp, is one of the few biologically well-defined lncRNAs and functions as a regulator of trans-silencing (Woo and Kingston 2007) . It is highly expressed in many human cancers and is a negative prognostic indicator in colon, liver, breast, and pancreatic cancer patient survival, thereby evidencing a close association with increase in cancer cell metastasis (Kim et al. 2013; Kogo et al. 2011 ). In addition, HOTAIR is important in regulating the expression of genes involved in cisplatin resistance of human lung adenocarcinoma cells (Liu et al. 2013) . Similarly, our present study found that HOTAIR contributes to the resistance of endometrial cancer to cisplatin, and HOTAIR inhibition increases the autophagy in vitro. It is uncertain how any lncRNA might be responsible for autophagy-related chemoresistance. In our current study, we have shown that HOTAIR contributes to the cisplatin resistance of Ishikawa CP cells through autophagy pathway, demonstrating a mechanistic link among HOTAIR, autophagy, and cisplatin resistance in endometrial cancer. Cisplatin resistance is regulated by autophagy and autophagy regulated by lncRNA has been extensively documented in the literature (Liu et al. 2015; Wang and Wu 2014) . However, the ability of lncRNA to reverse chemoresistance through regulation of autophagy activity and in turn inhibit proliferation in endometrial cancer was previously unrecognized.
HOTAIR works together with the PRC2 and LSD1/ CoREST/REST, which causes the modifications of DNA-binding proteins and eventually regulates overall gene expressions (Chang and Hung 2012; Cao et al. 2012; Semaan et al. 2011; Murati et al. 2012) . In HOTAIR-induced cisplatin resistance of lung adenocarcinoma cells, p21 might be an important mediator (Liu et al. 2013) . In the present study, transfection of HOTAIR1 siRNA significantly decreased the increased expression of Beclin-1, MDR, and P-gp in Ishikawa CP cells, indicating that Beclin-1, MDR, and P-gp were the downstream targets of HOTAIR. Certainly, the molecular mechanisms involved in HOTAIR-induced Beclin-1, MDR, and P-gp downregulation need to be further elucidated in future.
In summary, we have clearly demonstrated that lncRNAs, specifically HOTAIR, can regulate the cisplatin-resistance ability of human endometrial cancer cells through regulation of autophagy by influencing Beclin-1, MDR, and P-gp expression. Our study provides new insights and valuable information towards development of a complete understanding of the pathogenesis and development of the cisplatin resistance in human endometrial cancer. This raises the possibility that anti-HOTAIR may have potential therapeutic value for treating cisplatin-resistant endometrial cancer patients.
